Cargando…

A model for ‘reverse innovation’ in health care

‘Reverse innovation,’ a principle well established in the business world, describes the flow of ideas from emerging to more developed economies. There is strong and growing interest in applying this concept to health care, yet there is currently no framework for describing the stages of reverse inno...

Descripción completa

Detalles Bibliográficos
Autores principales: DePasse, Jacqueline W, Lee, Patrick T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844499/
https://www.ncbi.nlm.nih.gov/pubmed/24001367
http://dx.doi.org/10.1186/1744-8603-9-40
_version_ 1782293196314771456
author DePasse, Jacqueline W
Lee, Patrick T
author_facet DePasse, Jacqueline W
Lee, Patrick T
author_sort DePasse, Jacqueline W
collection PubMed
description ‘Reverse innovation,’ a principle well established in the business world, describes the flow of ideas from emerging to more developed economies. There is strong and growing interest in applying this concept to health care, yet there is currently no framework for describing the stages of reverse innovation or identifying opportunities to accelerate the development process. This paper combines the business concept of reverse innovation with diffusion of innovation theory to propose a model for reverse innovation as a way to innovate in health care. Our model includes the following steps: (1) identifying a problem common to lower- and higher-income countries; (2) innovation and spread in the low-income country (LIC); (3) crossover to the higher-income country (HIC); and (4) innovation and spread in the HIC. The crucial populations in this pathway, drawing from diffusion of innovation theory, are LIC innovators, LIC early adopters, and HIC innovators. We illustrate the model with three examples of current reverse innovations. We then propose four sets of specific actions that forward-looking policymakers, entrepreneurs, health system leaders, and researchers may take to accelerate the movement of promising solutions through the reverse innovation pipeline: (1) identify high-priority problems shared by HICs and LICs; (2) create slack for change, especially for LIC innovators, LIC early adopters, and HIC innovators; (3) create spannable social distances between LIC early adopters and HIC innovators; and (4) measure reverse innovation activity globally.
format Online
Article
Text
id pubmed-3844499
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38444992013-12-02 A model for ‘reverse innovation’ in health care DePasse, Jacqueline W Lee, Patrick T Global Health Debate ‘Reverse innovation,’ a principle well established in the business world, describes the flow of ideas from emerging to more developed economies. There is strong and growing interest in applying this concept to health care, yet there is currently no framework for describing the stages of reverse innovation or identifying opportunities to accelerate the development process. This paper combines the business concept of reverse innovation with diffusion of innovation theory to propose a model for reverse innovation as a way to innovate in health care. Our model includes the following steps: (1) identifying a problem common to lower- and higher-income countries; (2) innovation and spread in the low-income country (LIC); (3) crossover to the higher-income country (HIC); and (4) innovation and spread in the HIC. The crucial populations in this pathway, drawing from diffusion of innovation theory, are LIC innovators, LIC early adopters, and HIC innovators. We illustrate the model with three examples of current reverse innovations. We then propose four sets of specific actions that forward-looking policymakers, entrepreneurs, health system leaders, and researchers may take to accelerate the movement of promising solutions through the reverse innovation pipeline: (1) identify high-priority problems shared by HICs and LICs; (2) create slack for change, especially for LIC innovators, LIC early adopters, and HIC innovators; (3) create spannable social distances between LIC early adopters and HIC innovators; and (4) measure reverse innovation activity globally. BioMed Central 2013-08-30 /pmc/articles/PMC3844499/ /pubmed/24001367 http://dx.doi.org/10.1186/1744-8603-9-40 Text en Copyright © 2013 DePasse and Lee; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Debate
DePasse, Jacqueline W
Lee, Patrick T
A model for ‘reverse innovation’ in health care
title A model for ‘reverse innovation’ in health care
title_full A model for ‘reverse innovation’ in health care
title_fullStr A model for ‘reverse innovation’ in health care
title_full_unstemmed A model for ‘reverse innovation’ in health care
title_short A model for ‘reverse innovation’ in health care
title_sort model for ‘reverse innovation’ in health care
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844499/
https://www.ncbi.nlm.nih.gov/pubmed/24001367
http://dx.doi.org/10.1186/1744-8603-9-40
work_keys_str_mv AT depassejacquelinew amodelforreverseinnovationinhealthcare
AT leepatrickt amodelforreverseinnovationinhealthcare
AT depassejacquelinew modelforreverseinnovationinhealthcare
AT leepatrickt modelforreverseinnovationinhealthcare